MT. COOK PHARMA
Similar Organizations
Astra
Astra is a Health Care company.
Aventis Pharma Ltd
Aventis Pharma Ltd is a Health Care company.
Corvita
Corvita is a Health Care company.
More informations about "Mt. Cook Pharma"
Mt. Cook Pharma - Crunchbase Company Profile & Funding
Cook Pharma is located in Princeton, New Jersey, United States. Who are Mt. Cook Pharma's competitors? Alternatives and possible competitors to Mt. Cook Pharma may include Moorea …See details»
Mt. Cook Pharma, Inc.: Drug pipelines, Patents, Clinical trials
Explore Mt. Cook Pharma, Inc. with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Nervous System Diseases, Technology Platform:Small molecule drug, …See details»
Mt. Cook Pharma - M&A Summary and Business Overview - Mergr
Mt. Cook Pharma is headquartered in Princeton, New Jersey. What sector is Mt. Cook Pharma in? Mt. Cook Pharma is a healthcare services company. When was Mt. Cook Pharma …See details»
Mt. Cook Pharma - Crunchbase
Mt. Cook Pharma, Corvita, Astra, Aventis Pharma Ltd, Magainin Pharmaceuticals Inc., and Moorea Holdings operate in the pharmaceutical and healthcare industry. Corvita, Astra, …See details»
MCP-204 - Drug Targets, Indications, Patents - Synapse - Patsnap
Understand key drug designations in just a few clicks with Synapse. MCP-204: a δ opioid receptor agonists Drug, Initially developed by Mt. Cook Pharma, Inc., Now, its global highest R&D …See details»
DPI-290 - Drug Targets, Indications, Patents - Synapse - Patsnap
Understand key drug designations in just a few clicks with Synapse. DPI-290: a δ opioid receptor agonists, μ opioid receptor antagonists Drug, Initially developed by Enhance Biotech, Inc.,See details»
Research programme: opioid delta receptor agonists - Mt Cook …
Mt Cook Pharma (formerly known as Mount Cook Biosciences) is developing selective opioid delta receptor agonists for the treatment of urological conditions,See details»
Alan Joslyn - President and CEO - Mt Cook Pharma | LinkedIn
President and CEO at Mt Cook Pharma · Experience: Mt Cook Pharma · Location: Princeton · 1 connection on LinkedIn. View Alan Joslyn’s profile on LinkedIn, a professional community of 1...See details»
Mt. Cook Pharma - Tech Stack, Apps, Patents & Trademarks
Mt. Cook Pharma has 1 registered patent in the ' Medical Or Veterinary Science; Hygiene ' category, according to IPqwery.See details»
The latest R&D info about Mt. Cook Pharma, Inc.: pipelines, …
Find drug R&D information for Mt. Cook Pharma, Inc.. including drug pipeline ... Mt. Cook Pharma, Inc. has a total of 0 Literature ...See details»
Catalent Completes Acquisition of Cook Pharmica
Oct 24, 2017 · Ctalent has completed the acquisition of Cook Pharmica, a provider of drug substance and drug product manufacturing and related services.See details»
The MT Group, Top Emerging CRO-2021 - contract-research …
What Makes the MT Group Your Go-To Biospecimen CRO? One answer is medical expertise and many years “in the industry trenches.” Having worked together for over 30 years and analyzing …See details»
MCP-203 - Drug Targets, Indications, Patents - Synapse
MCP-203: a δ opioid receptor agonists Drug, Initially developed by Mt. Cook Pharma, Inc., Now, its global highest R&D status is Pending, Mechanism: δ opioid receptor agonists (δ-opioid …See details»
Cook Pharmica, LLC - Crunchbase Company Profile & Funding
Bloomington, Indiana, Cook Pharmica is a wholly owned subsidiary of the Cook Group, which includes the largest privately held medical device manufacturer in the world, Cook Medical. …See details»
Tom Wicks - VP-RA/QA - Mt. Cook Pharma | LinkedIn
VP-RA/QA at Mt. Cook Pharma · Experience: Mt. Cook Pharma · Location: Princeton · 7 connections on LinkedIn. View Tom Wicks’ profile on LinkedIn, a professional community of 1 …See details»
Alan Joslyn - President and Chief Executive Officer - Crunchbase
He previously served as the President and Chief Executive Officer of Mt Cook Pharma, a company focused on the development of products to treat urologic disorders. Previously, Dr. …See details»
Resiniferatoxin - Sorrento Therapeutics - AdisInsight - Springer
Sep 11, 2023 · Developer ICOS Corporation; Mt Cook Pharma; National Institutes of Health (USA); Sorrento Therapeutics ... If your organization has a subscription, there are several …See details»
MCP-205 - Drug Targets, Indications, Patents - Synapse
MCP-205: a δ opioid receptor agonists Drug, Initially developed by Mt. Cook Pharma, Inc., Now, its global highest R&D status is Pending, Mechanism: δ opioid receptor agonists(δ-opioid …See details»
DPI-353 - Drug Targets, Indications, Patents - Synapse - Patsnap
DPI-353: a δ opioid receptor agonists Drug, Initially developed by Ardent Pharmaceuticals, Inc., Now, its global highest R&D status is Pending, Mechanism: δ opioid receptor agonists (δ …See details»
Thomas Wicks - Vice President of Global RA / QA - Crunchbase
Thomas Wicks is the Vice President of Global RA/QA at Tarsa Therapeutics. Dr. Wicks has over 25 years’ experience in regulatory strategic planning and execution. Prior to joining Tarsa, Dr. …See details»